Pooja Gaur1, Kerriann M Casey2, Jan Kubanek3, Ningrui Li4, Morteza Mohammadjavadi5, Yamil Saenz5, Gary H Glover5, Donna M Bouley2, Kim Butts Pauly5. 1. Department of Radiology, Stanford University, Stanford, CA, USA. Electronic address: pgaur@stanford.edu. 2. Department of Comparative Medicine, Stanford University, Stanford, CA, USA. 3. Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA. 4. Department of Electrical Engineering, Stanford University, Stanford, CA, USA. 5. Department of Radiology, Stanford University, Stanford, CA, USA.
Abstract
BACKGROUND: Neuromodulation by transcranial focused ultrasound (FUS) offers the potential to non-invasively treat specific brain regions, with treatment location verified by magnetic resonance acoustic radiation force imaging (MR-ARFI). OBJECTIVE: To investigate the safety of these methods prior to widespread clinical use, we report histologic findings in two large animal models following FUS neuromodulation and MR-ARFI. METHODS: Two rhesus macaques and thirteen Dorset sheep were studied. FUS neuromodulation was targeted to the primary visual cortex in rhesus macaques and to subcortical locations, verified by MR-ARFI, in eleven sheep. Both rhesus macaques and five sheep received a single FUS session, whereas six sheep received repeated sessions three to six days apart. The remaining two control sheep did not receive ultrasound but otherwise underwent the same anesthetic and MRI procedures as the eleven experimental sheep. Hematoxylin and eosin-stained sections of brain tissue (harvested zero to eleven days following FUS) were evaluated for tissue damage at FUS and control locations as well as tissue within the path of the FUS beam. TUNEL staining was used to evaluate for the presence of apoptosis in sheep receiving high dose FUS. RESULTS: No FUS-related pre-mortem histologic findings were observed in the rhesus macaques or in any of the examined sheep. Extravascular red blood cells (RBCs) were present within the meninges of all sheep, regardless of treatment group. Similarly, small aggregates of perivascular RBCs were rarely noted in non-target regions of neural parenchyma of FUS-treated (8/11) and untreated (2/2) sheep. However, no concurrent histologic abnormalities were observed, consistent with RBC extravasation occurring as post-mortem artifact following brain extraction. Sheep within the high dose FUS group were TUNEL-negative at the targeted site of FUS. CONCLUSIONS: The absence of FUS-related histologic findings suggests that the neuromodulation and MR-ARFI protocols evaluated do not cause tissue damage.
BACKGROUND: Neuromodulation by transcranial focused ultrasound (FUS) offers the potential to non-invasively treat specific brain regions, with treatment location verified by magnetic resonance acoustic radiation force imaging (MR-ARFI). OBJECTIVE: To investigate the safety of these methods prior to widespread clinical use, we report histologic findings in two large animal models following FUS neuromodulation and MR-ARFI. METHODS: Two rhesus macaques and thirteen Dorset sheep were studied. FUS neuromodulation was targeted to the primary visual cortex in rhesus macaques and to subcortical locations, verified by MR-ARFI, in eleven sheep. Both rhesus macaques and five sheep received a single FUS session, whereas six sheep received repeated sessions three to six days apart. The remaining two control sheep did not receive ultrasound but otherwise underwent the same anesthetic and MRI procedures as the eleven experimental sheep. Hematoxylin and eosin-stained sections of brain tissue (harvested zero to eleven days following FUS) were evaluated for tissue damage at FUS and control locations as well as tissue within the path of the FUS beam. TUNEL staining was used to evaluate for the presence of apoptosis in sheep receiving high dose FUS. RESULTS: No FUS-related pre-mortem histologic findings were observed in the rhesus macaques or in any of the examined sheep. Extravascular red blood cells (RBCs) were present within the meninges of all sheep, regardless of treatment group. Similarly, small aggregates of perivascular RBCs were rarely noted in non-target regions of neural parenchyma of FUS-treated (8/11) and untreated (2/2) sheep. However, no concurrent histologic abnormalities were observed, consistent with RBC extravasation occurring as post-mortem artifact following brain extraction. Sheep within the high dose FUS group were TUNEL-negative at the targeted site of FUS. CONCLUSIONS: The absence of FUS-related histologic findings suggests that the neuromodulation and MR-ARFI protocols evaluated do not cause tissue damage.
Authors: Stuart Hameroff; Michael Trakas; Chris Duffield; Emil Annabi; M Bagambhrini Gerace; Patrick Boyle; Anthony Lucas; Quinlan Amos; Annemarie Buadu; John J Badal Journal: Brain Stimul Date: 2012-05-29 Impact factor: 8.955
Authors: Yuexi Huang; Laura Curiel; Aleksandra Kukic; Donald B Plewes; Rajiv Chopra; Kullervo Hynynen Journal: Med Phys Date: 2009-06 Impact factor: 4.071
Authors: Rachel R Bitton; Elena Kaye; Frederick M Dirbas; Bruce L Daniel; Kim Butts Pauly Journal: J Magn Reson Imaging Date: 2011-12-14 Impact factor: 4.813
Authors: V Chaplin; M A Phipps; S V Jonathan; W A Grissom; P F Yang; L M Chen; C F Caskey Journal: Int J Comput Assist Radiol Surg Date: 2019-05-08 Impact factor: 2.924
Authors: Robert F Dallapiazza; Kelsie F Timbie; Stephen Holmberg; Jeremy Gatesman; M Beatriz Lopes; Richard J Price; G Wilson Miller; W Jeffrey Elias Journal: J Neurosurg Date: 2017-04-21 Impact factor: 5.115
Authors: Anton Fomenko; Clemens Neudorfer; Robert F Dallapiazza; Suneil K Kalia; Andres M Lozano Journal: Brain Stimul Date: 2018-08-23 Impact factor: 8.955
Authors: Huiwen Luo; Michelle K Sigona; Thomas J Manuel; Marshal A Phipps; Li M Chen; Charles F Caskey; William A Grissom Journal: Magn Reson Med Date: 2022-08-02 Impact factor: 3.737
Authors: Davide Folloni; Elsa Fouragnan; Marco K Wittmann; Lea Roumazeilles; Lev Tankelevitch; Lennart Verhagen; David Attali; Jean-François Aubry; Jerome Sallet; Matthew F S Rushworth Journal: Sci Adv Date: 2021-12-15 Impact factor: 14.136